Hoestbruistabletten Acetylcysteïne Htp (Acetylcysteine)

Hoestbruistabletten Acetylcysteïne Htp is indicated for conditions where thick or sticky mucus impairs breathing. It is commonly used in the following situations:

• Acute productive cough associated with viral or bacterial infections
• Chronic bronchitis with persistent mucus production
• Chronic obstructive pulmonary disease (COPD) exacerbations
• Post‑operative or post‑intubation airway clearance
• Other respiratory disorders characterized by viscous secretions

• Acetylcysteine acts as a mucolytic by cleaving disulfide bonds within mucus glycoproteins, thereby reducing the polymeric network that gives mucus its high viscosity. This chemical disruption lowers mucus thickness and elasticity, allowing ciliary action and coughing to clear secretions more efficiently from the airways.

Adverse reactions to Hoestbruistabletten Acetylcysteïne Htp are generally mild, but some users may experience more serious events.

Common

• Nausea or upset stomach
• Mild abdominal discomfort
• Unpleasant taste or after‑taste
• Headache
• Skin flushing or mild rash

Serious

• Severe allergic reaction (anaphylaxis, angioedema)
• Bronchospasm in susceptible individuals
• Persistent vomiting or diarrhea

Before using Hoestbruistabletten Acetylcysteïne Htp, consider the following safety points:

• Do not use if you have a known hypersensitivity to acetylcysteine or any excipients.
• Use caution in patients with active peptic ulcer disease, as gastric irritation may occur.
• Pregnant or breastfeeding individuals should consult a healthcare professional, as safety data are limited.
• Individuals with asthma should monitor for bronchospasm after administration.
• Keep out of reach of children; accidental ingestion may cause gastrointestinal upset.
• Store at room temperature, protected from moisture and direct sunlight.

Acetylcysteine may affect the activity of certain medications. Review the following interaction guidance:

Avoid

• Nitroprusside, because acetylcysteine can potentiate hypotensive effects.
• Activated charcoal, which may adsorb acetylcysteine and reduce its efficacy.

Use with caution

• Anticoagulants (e.g., warfarin) – monitor coagulation parameters as mucolytics can alter platelet function.
• Antibiotics such as carbapenems – rare reports of altered plasma levels.
• Bronchodilators – observe for additive bronchospasm in asthmatic patients.
• Other mucolytic agents – combined use may increase risk of gastrointestinal irritation.